1. Jing, Xu, Ren, Dandan, Gao, Fei, Tang, Wei, Zhang, Yan. 2020. Gene deficiency or pharmacological inhibition of PDCD4-mediated FGR signaling protects against acute kidney injury. In Acta pharmaceutica Sinica. B, 11, 394-405. doi:10.1016/j.apsb.2020.10.024. https://pubmed.ncbi.nlm.nih.gov/33643819/
2. Patel, M, Faulkner, L, Katz, D R, Brickell, P M. . The c-fgr proto-oncogene: expression in Epstein-Barr-virus-infected B lymphocytes and in cells of the myelomonocytic and granulocytic lineages. In Pathobiology : journal of immunopathology, molecular and cellular biology, 59, 289-92. doi:. https://pubmed.ncbi.nlm.nih.gov/1652975/
3. Zeng, Chumei, Liu, Huiying, Wang, Zilian, Li, Jingting. 2023. Novel insights into the complex interplay of immune dysregulation and inflammatory biomarkers in preeclampsia and fetal growth restriction: A two-step Mendelian randomization analysis. In Journal of translational autoimmunity, 8, 100226. doi:10.1016/j.jtauto.2023.100226. https://pubmed.ncbi.nlm.nih.gov/38225945/
4. Liu, Yan, Shi, Jun-Zhuo, Jiang, Rong, Döring, Yvonne, Yan, Yi. 2022. Regulatory T Cell-Related Gene Indicators in Pulmonary Hypertension. In Frontiers in pharmacology, 13, 908783. doi:10.3389/fphar.2022.908783. https://pubmed.ncbi.nlm.nih.gov/35712711/